CVA Family Office’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $307K | Hold |
8,000
| – | – | 0.04% | 226 |
|
|
2025
Q1 | $310K | Hold |
8,000
| – | – | 0.05% | 208 |
|
|
2024
Q4 | $271K | Hold |
8,000
| – | – | 0.04% | 226 |
|
|
2024
Q3 | $327K | Hold |
8,000
| – | – | 0.05% | 191 |
|
|
2024
Q2 | $308K | Hold |
8,000
| – | – | 0.06% | 191 |
|
|
2024
Q1 | $343K | Hold |
8,000
| – | – | 0.06% | 180 |
|
|
2023
Q4 | $296K | Hold |
8,000
| – | – | 0.06% | 188 |
|
|
2023
Q3 | $290K | Sell |
8,000
-202
| -2% | -$7.32K | 0.07% | 173 |
|
|
2023
Q2 | $292K | Hold |
8,202
| – | – | 0.06% | 174 |
|
|
2023
Q1 | $292K | Sell |
8,202
-179
| -2% | -$6.37K | 0.07% | 172 |
|
|
2022
Q4 | $295K | Buy |
8,381
+8,179
| +4,049% | +$287K | 0.07% | 156 |
|
|
2022
Q3 | $6K | Hold |
202
| – | – | ﹤0.01% | 693 |
|
|
2022
Q2 | $11K | Hold |
202
| – | – | ﹤0.01% | 628 |
|
|
2022
Q1 | $11K | Hold |
202
| – | – | ﹤0.01% | 659 |
|
|
2021
Q4 | $11K | Buy |
+202
| New | +$11K | ﹤0.01% | 628 |
|
|
2021
Q3 | – | Sell |
-202
| Closed | -$10K | – | 565 |
|
|
2021
Q2 | $10K | Buy |
+202
| New | +$10K | ﹤0.01% | 646 |
|